Suppr超能文献

后疫情时代重振癌症临床试验:是时候进行改革了。

Revitalising cancer trials post-pandemic: time for reform.

机构信息

Department of Medical Oncology, Guy's & St Thomas NHS Foundation Trust, London, UK.

Institute of Cancer Policy, King's College London, London, UK.

出版信息

Br J Cancer. 2023 Apr;128(8):1409-1414. doi: 10.1038/s41416-023-02224-y. Epub 2023 Mar 23.

Abstract

The COVID-19 pandemic posed significant risk to the health of cancer patients, compromised standard cancer care and interrupted clinical cancer trials, prompting dramatic streamlining of services. From this health crisis has emerged the opportunity to carry forward an unexpected legacy of positive reforms to clinical cancer research, where conventionally convoluted approvals processes, inefficient trial design, procedures and data gathering could benefit from the lessons in rationalisation learned during the pandemic.

摘要

COVID-19 大流行给癌症患者的健康带来了重大风险,影响了标准的癌症治疗并中断了临床癌症试验,促使服务大幅简化。这场卫生危机带来了一个意想不到的机会,可以将临床癌症研究中的积极改革延续下去,在这些研究中,传统上复杂的审批流程、效率低下的试验设计、程序和数据收集都可以从大流行期间学到的合理化经验中受益。

相似文献

1
Revitalising cancer trials post-pandemic: time for reform.后疫情时代重振癌症临床试验:是时候进行改革了。
Br J Cancer. 2023 Apr;128(8):1409-1414. doi: 10.1038/s41416-023-02224-y. Epub 2023 Mar 23.
9
Navigating Cancer Care in the COVID-19 Era.在新冠疫情时代的癌症护理
Cancer Discov. 2022 Feb;12(2):283. doi: 10.1158/2159-8290.CD-ND2021-0116. Epub 2021 Dec 9.

本文引用的文献

2
Real-World Evidence - Where Are We Now?真实世界证据——我们目前处于什么阶段?
N Engl J Med. 2022 May 5;386(18):1680-1682. doi: 10.1056/NEJMp2200089. Epub 2022 Apr 30.
3
Federated Networks for Distributed Analysis of Health Data.用于健康数据分布式分析的联邦网络。
Front Public Health. 2021 Sep 30;9:712569. doi: 10.3389/fpubh.2021.712569. eCollection 2021.
5
9
The National Lung Matrix Trial of personalized therapy in lung cancer.国家肺癌矩阵试验:肺癌个体化治疗。
Nature. 2020 Jul;583(7818):807-812. doi: 10.1038/s41586-020-2481-8. Epub 2020 Jul 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验